ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
ResMed (RMD) Tops Q3 EPS by 3c, Revenues Miss
April 29, 2021 4:26 PM EDTResMed (NYSE: RMD) reported Q3 EPS of $1.30, $0.03 better than the analyst estimate of $1.27. Revenue for the quarter came in at $768.8 million versus the consensus estimate of $793.17 million.
Third Quarter 2021 HighlightsAll comparisons are to the prior year period
Revenue was comparable at $768.8 million; down 3% on a constant currency basisGAAP gross margin of 58.2%; non-GAAP gross margin contracted 40 bps to 59.6%Net operating profit increased 3%; non-GAAP operating profit up 2%GAAP diluted earnings... More